XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

Earnings Per Share | 9 Months Ended
--- | ---
Sep. 27, 2025
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share:
|  | Three Months Ended |  | Nine Months Ended
(in thousands, except per share amounts) |  | September 27, 2025 |  | September 28, 2024 |  | September 27, 2025 |  | September 28, 2024
Numerator: |  |  |  |  |  |  |  |
Net income as reported |  | $ | 69,522 |  |  | $ | 58,058 |  |  | $ | 170,435 |  |  | $ | 151,976 |
Denominator: |  |  |  |  |  |  |  |
Weighted average shares outstanding |  |  |  |  |  |  |  |
Basic |  | 24,837 |  |  | 24,796 |  |  | 24,786 |  |  | 24,822 |
Effect of dilutive securities |  | 265 |  |  | 229 |  |  | 203 |  |  | 218 |
Diluted |  | 25,102 |  |  | 25,025 |  |  | 24,989 |  |  | 25,040 |
Earnings Per Share: |  |  |  |  |  |  |  |
Basic earnings per share |  | $ | 2.80 |  |  | $ | 2.34 |  |  | $ | 6.88 |  |  | $ | 6.12 |
Diluted earnings per share |  | $ | 2.77 |  |  | $ | 2.32 |  |  | $ | 6.82 |  |  | $ | 6.07 |
Potential shares of common stock attributable to performance share units, stock options and restricted stock units excluded from the earnings per share calculation because their effect would be anti-dilutive were 101,354 and 124,197 for the three months ended September 27, 2025 and September 28, 2024, respectively, and 322,843 and 136,635 for the nine months ended September 27, 2025 and September 28, 2024, respectively. Share Repurchase Program On April 25, 2024, the Company's Board of Directors authorized a three-year program to repurchase up to $300.0 million in the aggregate of shares of the Company's stock for the period from May 1, 2024 to April 30, 2027 ("2024 program") to replace its previous 2021 program. The Company did not repurchase any shares of its common stock for the three months ended September 27, 2025. During the nine months ended September 27, 2025, the Company repurchased 120,689 shares of its common stock totaling $27.4 million pursuant to the 2024 program. During the nine months ended September 28, 2024, the Company repurchased 179,311 shares of its common stock totaling $40.9 million, of which, $38.9 million was pursuant to the 2021 program and $2.0 million was pursuant to the 2024 program.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration